Your browser doesn't support javascript.
loading
PRADC1: a novel metabolic-responsive secretory protein that modulates physical activity and adiposity.
Rodriguez, Susana; Stewart, Ashley N; Lei, Xia; Cao, Xi; Little, Hannah C; Fong, Vincent; Sarver, Dylan C; Wong, G William.
Afiliação
  • Rodriguez S; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Stewart AN; Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lei X; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Cao X; Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Little HC; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Fong V; Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sarver DC; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wong GW; Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
FASEB J ; 33(12): 14748-14759, 2019 12.
Article em En | MEDLINE | ID: mdl-31689374
Interorgan communication mediated by secreted proteins plays a pivotal role in metabolic homeostasis, yet the function of many circulating secretory proteins remains unknown. Here, we describe the function of protease-associated domain-containing 1 (PRADC1), an enigmatic secretory protein widely expressed in humans and mice. In metabolically active tissues (liver, muscle, fat, heart, and kidney), we showed that Pradc1 expression is significantly suppressed by refeeding and reduced in kidney and brown fat in the context of obesity. PRADC1 is dispensable for whole-body metabolism when mice are fed a low-fat diet. However, in obesity induced by high-fat feeding, PRADC1-deficient female mice have reduced weight gain and adiposity despite similar caloric intake. Decreased fat mass is attributed, in part, to increased metabolic rate, physical activity, and energy expenditure in these animals. Reduced adiposity in PRADC1-deficient mice, however, does not improve systemic glucose and lipid metabolism, insulin sensitivity, liver steatosis, or adipose inflammation. Thus, in PRADC1-deficient animals, decreased fat mass and enhanced physical activity are insufficient to confer a healthy metabolic phenotype in the context of an obesogenic diet. Our results shed light on the physiologic function of PRADC1 and the complex regulation of metabolic health.-Rodriguez, S., Stewart, A. N., Lei, X., Cao, X., Little, H. C., Fong, V., Sarver, D. C., Wong, G. W. PRADC1: a novel metabolic-responsive secretory protein that modulates physical activity and adiposity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos e Proteínas de Sinalização Intercelular / Adiposidade / Metabolismo dos Lipídeos / Movimento Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos e Proteínas de Sinalização Intercelular / Adiposidade / Metabolismo dos Lipídeos / Movimento Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article